Study evaluates polygenic risk score for prostate cancer risk prediction
A prostate cancer polygenic risk score (PRS) has limited utility for enhancing prostate cancer screening, according to a new study published in JAMA Internal Medicine.
Conquer Cancer awards given to five hematology-oncology fellows
Young Investigator Awards provide research funding to promising young physicians during the final years of training to support their transition to a faculty appointment and to encourage quality research in clinical oncology. Yu-Wei Chen, MD, MS; R. Dixon Dorand, MD, PhD, and Brian Grieb, MD, PhD, are recipients of Young Investigator Awards.
National Cancer Institute honors Berlin’s contributions, leadership
Jordan Berlin, MD, Ingram Professor of Cancer Research and director of the Division of Hematology and Oncology, is a 2022 recipient of the National Cancer Institute (NCI) Director’s Award.